The Carotid and Middle Cerebral Artery Occlusion Surgery Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 330 participants.
Also called NCT01758614
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 330 participants
- Sponsor
- Registry
-
NCT01758614
-
- Other papers using this trial's data
- CT Perfusion for Predicting Ischemic Stroke in Patients With Symptomatic Carotid or Middle Cerebral Artery Occlusion: A Post Hoc Analysis of the CMOSS Study
- Determining the Optimal Age for Extracranial-Intracranial Bypass Surgery: A Post Hoc Analysis of the CMOSS Randomized Trial
- Extracranial-Intracranial Bypass and Risk of Stroke and Death in Patients With Symptomatic Artery Occlusion: The CMOSS Randomized Clinical Trial
- Qualifying Event and Recurrence of Ischemic Stroke in Symptomatic Artery Occlusion: A Post Hoc Analysis of CMOSS
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01758614. Randomized; single masking; primary purpose treatment. Start 2013-06-06 (actual); primary completion 2018-03-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Carotid and Middle Cerebral Artery Occlusion Surgery Study
- Acronym
- CMOSS
- Condition
- Carotid Artery Occlusion
- Condition
- Middle Cerebral Artery Occlusion
- Condition
- Stroke
- Intervention (Procedure)
- bypass surgery
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Xuanwu Hospital, Beijing
Record details
- Record id
cardio:ct-nct01758614- Content hash
91367bf8e2c28172840a0ac0d9f5947bca75c53bec7ac9015fa601b11932b535